NCAPH and cervical cancer: Our data demonstrated a novel molecular pathway in cervical cancer, that is, TRIM21 degrades NCAPH through K-11 ubiquitination, thus inhibiting the activation of the downstream AKT/mTOR pathway, promoting autophagosome formation and inhibiting cell proliferation.